Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
$IKT MomentumIts trading | jedijazz | investorshub | 04/12/2023 10:46:49 PM |
best news of the day | conix | investorshub | 04/12/2023 10:15:46 PM |
$IKT MomentumIts trading last trade up | conix | investorshub | 04/12/2023 1:07:10 PM |
$IKT Price gaining | ProfitScout | investorshub | 04/12/2023 4:48:42 AM |
$IKT When is this gonna take off? | jedijazz | investorshub | 04/12/2023 3:47:38 AM |
$IKT MomentumIts gaining | conix | investorshub | 04/12/2023 2:23:04 AM |
$IKT MomentumIts gaining up | conix | investorshub | 04/12/2023 12:03:53 AM |
Price gaining | CarlCarlMcB | investorshub | 04/12/2023 12:03:33 AM |
Price gaining | conix | investorshub | 04/11/2023 11:22:57 PM |
$IKT Looks pretty positive | conix | investorshub | 04/11/2023 8:14:10 PM |
MomentumIts gaining last up | ProfitScout | investorshub | 04/11/2023 1:47:14 PM |
$IKT The gaining last up | ProfitScout | investorshub | 04/11/2023 1:10:59 PM |
$IKT Price now | conix | investorshub | 04/11/2023 8:49:34 AM |
short squeeze all day | estreet7883 | investorshub | 04/11/2023 8:27:44 AM |
$IKT short squeeze article | conix | investorshub | 04/11/2023 8:12:14 AM |
$IKT Anyone hear anything lately? Want to see this one go | conix | investorshub | 04/11/2023 6:50:49 AM |
Price trading | kzivann | investorshub | 04/10/2023 10:15:58 PM |
we got news | conix | investorshub | 04/10/2023 8:36:23 PM |
short squeeze | INFINITI | investorshub | 04/10/2023 6:20:27 PM |
bears and bulls | conix | investorshub | 04/10/2023 5:42:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...